DETAILS, FICTION AND ABBV-744 IN ACUTE MYELOID LEUKEMIA (AML)

These side effects were being notably milder compared to an inhibitor of equally bromodomains. An in depth molecular Evaluation also discovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor- "Our study unveiled the critical position on the KLF16/MYC regulatory axis in modulating